Metabolic syndrome biomarkers relate to rate of cognitive decline in MCI and dementia stages of Alzheimer’s disease

BACKGROUND: The relationship between biomarkers of metabolic syndrome and insulin resistance, plasma triglyceride/HDL cholesterol (TG/HDL-C) ratio, on the rate of cognitive decline in mild cognitive impairment (MCI) and dementia stages of Alzheimer’s disease (AD) is unknown. The role of peripheral a...

Descripción completa

Detalles Bibliográficos
Autores principales: Pillai, Jagan A., Bena, James, Bekris, Lynn, Kodur, Nandan, Kasumov, Takhar, Leverenz, James B., Kashyap, Sangeeta R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018847/
https://www.ncbi.nlm.nih.gov/pubmed/36927447
http://dx.doi.org/10.1186/s13195-023-01203-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018847/
https://www.ncbi.nlm.nih.gov/pubmed/36927447
http://dx.doi.org/10.1186/s13195-023-01203-y

Ejemplares similares